胸主动脉腔内修复术中穿刺部位并发症
在芬兰赫尔辛基大学中心医院2010年3月至2022年12月完成的199例经股动脉胸主动脉腔内修复术(TEVAR)中,回顾性比较外科切开、ProGlide和MANTA三种股动脉闭合方式,技术成功率分别为97.6%、91.1%和93.1%(P=.213),穿刺部位血管并发症分别为3.5%、8.9%和10.3%(P=.290)。
要点
- 三种闭合方式技术成功率与穿刺部位血管并发症均无统计学显著差异。
- MANTA组术后发现2例假性动脉瘤并保守处理。
- 急诊手术和同期主动脉分支血运重建是TEVAR术后≥大出血的预测因素。
核心结论
- 经皮穿刺技术在本研究中显示在TEVAR期间具有可行性,但经皮技术的穿刺部位并发症数量高于开放入路,尽管差异无统计学意义。
- 在缺乏证据的情况下,新型MANTA塞式血管闭合器用于TEVAR的安全性有待进一步研究。
研究设计与样本
- 回顾性研究,纳入2010年3月至2022年12月在芬兰赫尔辛基大学中心医院完成的199例经股动脉TEVAR。
- 按术者偏好分为三组:外科切开和血管闭合组n=85(42.7%)、经皮穿刺ProGlide缝线式闭合组n=56(28.1%)、经皮穿刺超声引导MANTA塞式闭合组n=58(29.1%)。
主要发现
- 技术成功率:外科切开组97.6% vs ProGlide组91.1% vs MANTA组93.1%(P=.213)。
- 穿刺部位血管并发症发生率:外科切开组3.5% vs ProGlide组8.9% vs MANTA组10.3%(P=.290),MANTA组术后发现2例假性动脉瘤并保守处理。
- 单变量分析中血管闭合方式与≥大出血风险增加、早期死亡或住院时间无关。
- 多变量分析中TEVAR术后≥大出血的预测因素为急诊手术(比值比2.8,95%置信区间1.4-5.5;P=.003)和同期主动脉分支血运重建(比值比2.7,95%置信区间1.3-5.4;P=.008)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Percutaneous access and use of vascular closure devices facilitate thoracic endovascular aortic repair (TEVAR) procedures during local anesthesia and allow immediate detection of signs of spinal ischemia. However, the very large bore access (usually ≥22F sheath) associated with TEVAR increases the risk of vascular complications. In this study, we sought to define the safety and feasibility of two percutaneous femoral artery closure devices during TEVAR, in terms of access site vascular complications and major, life-threatening, or fatal bleeding (≥major) within 48 hours. Access site vascular complications were defined as technical failure of vascular closure or later formation of pseudoaneurysm. METHODS: From March 2010 to December 2022, 199 transfemoral TEVAR were performed at Helsinki University Central Hospital, Finland. We retrospectively categorized these into three groups, based on surgeon preference for the access technique and femoral artery closure method: (1) surgical cut-down and vessel closure, n = 85 (42.7%), (2) percutaneous access and vascular closure with suture-based ProGlide, n = 56 (28.1%), or (3) percutaneous access and vascular closure with ultrasound-guided plug-based MANTA, n = 58 (29.1%). The primary outcome measure was technical success of vascular closure and access site vascular complications during index hospitalization. Secondary outcome measures were ≥major bleeding, early mortality, and hospital stay. RESULTS: The technical success rate was 97.6% vs 91.1% vs 93.1% for surgical cut-down, ProGlide, and MANTA, respectively (P = .213). The rate of access site vascular complication was 3.5% vs 8.9% vs 10.3%, respectively (P = .290), with two pseudoaneurysms detected postoperatively and conservatively managed in the MANTA group. The vascular closure method was not associated with increased risk of ≥major bleeding, early mortality, or hospital stay on univariate analysis. Predictors for ≥major bleeding after TEVAR in multivariable analysis were urgent procedure (odds ratio: 2.8, 95% confidence interval: 1.4-5.5; P = .003) and simultaneous aortic branch revascularization (odds ratio: 2.7, 95% confidence interval: 1.3-5.4; P = .008). CONCLUSIONS: In this study, the technical success rates of the percutaneous techniques demonstrated their feasibility during TEVAR. However, the number of access site complications for percutaneous techniques was higher compared with open approach, although the difference was not statistically significant. In the lack of evidence, the safety of the new MANTA plug-based vascular closure for TEVAR warrants further investigation.
引用
- Dahlbacka S, Nykänen AI, Juvonen T, et al. Access site complications in thoracic endovascular aortic repair. J Vasc Surg. 2023. PMID: 38056701. doi:10.1016/j.jvs.2023.11.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。